U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result

There's little doubt these pharmaceutical companies' costs will soon be rising at least a little.The tariff war the U.S. is waging against most of the world stabilized somewhat earlier this month. But let's face facts -- it could easily flare up again. President Donald Trump appears quite committed to the idea of leveraging America's economic dominance, and no industry is immune to this dynamic.One could argue, however, that the pharmaceutical industry is especially vulnerable. Although the 25% import tarif ...